1CFA | Immune System Inhibitor | date | Sep 21, 1996 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
title | Solution Structure Of A Semi-Synthetic C5a Receptor Antagoni 5.2, 303k, Nmr, 20 Structures | ||||||||||
authors | X.Zhang, W.Boyar, N.Galakatos, N.C.Gonnella | ||||||||||
compound | source | ||||||||||
Molecule: Complement 5a Semi-Synthetic Antagonist Chain: A Fragment: Residues 1 - 71 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_plasmid: Pb-6 | ||||||||||
Molecule: Synthetic N-Terminal Tail Chain: B Fragment: Residues 72 - 75 Engineered: Yes |
|||||||||||
method | Solution NMR | ||||||||||
ligand | DAR | enzyme |
| ||||||||
note | 1CFA is a representative structure | ||||||||||
related structures | by homologous chain: 1C5A | ||||||||||
Gene Ontology |
| ||||||||||
Primary reference | Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding., Zhang X, Boyar W, Galakatos N, Gonnella NC, Protein Sci 1997 Jan;6(1):65-72. PMID:9007977 |
Data retrieval |
View 1CFA in 3D |
Visual 3D analysis of 1CFA |
Structure-derived information |
- Domain d1cfaa_, region A [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1CFA |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |